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Abstract Single nucleotide polymorphisms (SNPs) in
odorant receptor genes may influence the protein se-
quence and consequently also the function of the
receptors. An analysis of the HapMap data for human
OR3A1 was performed and provided evidence that
genetic differences subject to ancestry and gender
can be recognized. A genomic comparison of individ-
uals shows the diversity of odorant receptor genes and
therefore potentially the variety of the sense of smell.
At this time, two complete human genomes are avail-
able in public domain, which we used for this purpose.
Keywords Odorant receptor; OR3A1; Genomics; Single
nucleotide polymorphism.
Introduction
Olfaction is one of the most ancient senses [1] for
humans as well as for animals. During evolution this
sense was important for the finding and the identifi-
cation of nutrition, for the warnings of danger (rotten
food or enemies) as well as for reproduction. More-
over, human sensual pleasure (e.g., the odor of per-
fume) is one important aspect of life quality. So this
primal sense can be designated as a major agent for
communication between the individual and its envi-
ronment [2].
Odorants are volatile chemical compounds that
have to possess some special molecular properties
to reach the regio olfactoria – a small area of about
2.5 cm2 located at the roof of the two nasal cavities
of the human nose. Odorants are usually compounds
with low molecular weight (up to 300), with a re-
latively high vapor pressure, with some lipophilicity,
but they have to be water soluble to some extent.
At the regio olfactoria, the odorant molecules
have to pass a layer of mucous. The layer is enriched
with odorant binding proteins (OBPs), which belong
to the family of lipocalins that help to transport the
odor molecules to the olfactory receptors (ORs) [3].
The reception occurs on the olfactory cilia – every
olfactory neuron possesses 8–20 [1] of them – and so
sensory transmissions can be started. Signals that our
brain interprets as odor are produced by the ORs and
transmitted to the olfactory bulb through neurons.
Odorant receptors are G-protein coupled receptors
(GPCRs) and belong to class A sub-family (rhodop-
sin-like receptors, e.g. rhodopsin, olfactory, hormone,
and cannabinoid receptors). GPCRs consist of seven
membrane-spanning helices, which are connected by
three extracellular and three intracellular loops. The
G-protein binds on the intracellular side of the re-
ceptor. The seven transmembrane helices, which are
arranged anticlockwise as viewed from the extracel-
lular receptor side, are responsible for the anchoring
of the receptor in the cell membrane. Especially he-
lices 3–6 contain binding sites for ligands [4]. In
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contrast to the intracellular and extracellular loops,
the transmembrane domains of GPCRs are highly
conserved. Some motifs in the amino acid sequence
of the helices can be found in nearly all rhodopsin-
like receptors. These motifs are important for the
activation of the receptor.
In 2000, the first crystal structure of a mammalian
GPCR – that of bovine rhodopsin – has been resolved
(PDB ID: 1U19) [5]. Seven years later, the first struc-
ture of a human GPCR – the beta-2-receptor – has
been solved (PDB ID: 2R4R, 2R4S) [6]. A higher res-
olution (2.40 A˚) structure of the same receptor has
been published just recently (PDB ID: 2RH1) [7].
This structure is highly similar to bovine rhodopsin
in terms of the relative orientation of the seven helices.
No experimental structures of odorant receptors are
known up to now. Nevertheless, for some receptors
homology models based on rhodopsin as template
have been generated and used for docking studies
of related odor molecules [8–10]. As the sequence
similarity between rhodopsin and the investigated
receptors is rather poor (around 23%), evolutionary
criteria have been additionally applied in some cases
to support the alignment of the sequences and the
structures. Such homology models have also been
used to explain the association of helional and lilial
to odor receptors OR1A2 and Olfr49 [10, 11].
Generally, the odor impression results from the
interaction of the odor molecules with various odor-
ant receptors. The combination of the activation of
several ORs leads to a distinct fragrance recognition
in the brain [12, 13]. In special cases the fragrance
molecules form association complexes with the
odorant receptors without further activation, and this
is the reason for a competitive hindrance of the as-
sociation of activating odorants [14]. Such odor
molecules act as antagonists.
Olfactory receptor genes constitute the basis for the
sense of smell and are encoded by the largest mam-
malian gene superfamily. The human genome con-
tains around 850 odorant receptor genes, from which
approximately 400 are functional (The Human Olfac-
tory Data Exploratorium (HORDE) [15]). The rest
are pseudogenes, which are non-functional resulting
from nonsense mutations, deletions, and frameshift
[16]. For comparison, macaques possess approxi-
mately 700 functional olfactory receptor genes [17]
and mice, rats, and dogs even about 1000 [18, 19].
The OR genes are present on all human chro-
mosomes, except on chromosomes 20 and Y. Chro-
mosome 11 contains by far the most OR genes.
Generally, ORs are distributed in genomic clusters
with a typical intergenic distance of 20 kb, only 48
ORs are singletons.
Recently, our group has performed studies on the
odorant receptor cluster on human chromosome 17,
which contains 18 odorant receptor genes [20]. After
the extended search for orthologues of those odorant
receptor genes in chimpanzee, rat, and mouse genome,
comparisons subject to genomic location, similarities,
and function were made. These analyses provide some
interesting insights into the evolutionary relation
between the mentioned species. To explore further
details about the evolutionary development of odorant
receptors we studied in detail single nucleotide mu-
tations of the odorant receptor OR3A1 recognizing
helional. Additionally, the comparison between two
individual genomes with respect to various odorant
receptor families is described.
Results and discussion
Single nucleotide polymorphisms (SNPs)
in odorant receptor genes
A key aspect of research in genetics is associating
sequence variations with heritable phenotypes. The
most common variations are single nucleotide poly-
morphisms (SNPs), mutations of one single base,
which occurs every 100–300 bases in the human
genome and makes up about 90% of all variations
[21]. For a variation to be considered as SNP, it must
appear in at least 1% of the population.
SNPs can be located in both coding and non-cod-
ing regions of the gene. About 60% of all SNPs
involve the replacement of cytosine (C) by thymine
(T). The type of SNP can be – depending on the
location – synonymous or non-synonymous. Synon-
ymous variations do not have any consequences for
the protein sequence (so called silent mutations)
whereas non-synonymous variations cause changes
in the protein sequence and therefore may alter the
function of the protein.
Many SNPs have no detectable effect on cell func-
tion, but some others can help to determine the
likelihood of developing a particular disease (e.g.,
Alzheimer’s disease [22]). Moreover, they can have
a major impact on the human response to environ-
mental insults, drugs, and other therapies. For that
reason, SNPs are of great interest for biomedical
research and for developing pharmaceutical products
and medical diagnostics.
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SNPs do not change much from generation to gen-
eration [21], but they are supposed to differ in various
ethno geographic groups. Therefore, it can be hypoth-
esized that there is a diversity of olfactory sensitivity
amongst people, suggesting that also genetic differ-
ences can be found subject to different ancestry.
All known SNPs for human OR3A1 have been
examined and will be discussed in detail in the fol-
lowing part. Human OR3A1 (synonym hOR17-40)
genes are not only expressed in the nose but also in
testes, and so they are supposed to play a role in
sperm chemotaxis [23]. For that reason, also differ-
ences between men and women were regarded.
All SNPs annotated for OR3A1 were looked up
using the SNP database (http:==www.ncbi.nlm.nih.
gov=SNP=index.html) and basic facts, like ID num-
ber, location, and concerned nucleic acids and pro-
tein residues, were collected for each SNP. Then the
diversity in five different ancestries (European, Han
Chinese, Japanese, Sub-Saharan African, and African
American) as well as in both genders was analyzed
and percentages of occurring SNPs were calculated.
That was possible by the results of the International
HapMap Project, an organization whose goal is
to develop a haplotype map of the human genome
(the HapMap) and which examined about 90 people
(state: January 2008) of each descent and annotated
the SNPs for each tested individual [24].
In the following Table 1, collected data for all 9
SNPs are presented, including SNP ID and location.
Above mentioned percentages of occurrence of vari-
ation are given in the tables for every ancestry, dis-
tinguishing men and women. First numbers stand for
total occurrence, first values in parenthesis for occur-
rence in all tested women, and second numbers in
parenthesis for occurrence in all tested men. The first
column shows the original genetic situation, the sec-
ond column a mutation in one gene, and the third
column a mutation in both alleles.
There are six SNPs in OR3A1 that are located in
the non-coding region that means they are silent
mutations. The other three SNPs (Rs16952828,
Rs7218125, and Rs703903) are found in the coding
region and, therefore, cause a mutation in the protein
sequence. The degree of influence on olfactory per-
ception depends on the location of the altered resi-
due. In general, it can be assumed that mutations
which take place in the seven transmembrane helices
might influence the sense of smell because parts
of these regions are important for ligand binding.
Figure 1 shows an overview of the location of the
three SNPs on the coding region in OR3A1 on chro-
mosome 17 in a receptor model developed recently
by our group.
Rs16952828 – situated in the last third of helix 2 –
might affect ligand binding. Nevertheless, extraor-
dinary changes caused by a mutation in this place
cannot be expected, because according to Leffingwell
et al. [1] the largest binding site cavity falls in the
transmembrane domains TM 3–7. Although it is not
absolutely clear, it can be supposed that Rs703903
has an impact on olfaction because it is located at a
highly conserved position at the end of TM 3.
One of those three mutations, Rs7218125, causes
a loss of protein function that means it creates a
pseudogene. Figure 1 shows that this SNP is located
in the extracellular loop between helix 2 and 3. This
region might be important for ligand binding. It is
obvious, that none of the tested individuals possesses
this variation on both genes (A=A) regardless of
which ancestry. Another interesting fact is, that this
SNP does not concern tested Europeans as well as no
Han Chinese and Japanese women. Regarding tested
Sub-Saharan Africans and African Americans it is
apparent that men are stronger affected by the mu-
tation than women (only 8.3% of all tested Sub-
Saharan African women show this variation whereas
18.2% of all tested men of same descent).
Another SNP situated on the coding region is
Rs703903. It leads to a change from glutamine to
arginine in the protein sequence. Surprisingly, all
analyzed Han Chinese and Japanese people possess
a mutation on both genes (T=T). Also Sub-Saharan
African and European individuals have a variation
on one gene (C=T) to a higher percentage than
primary genetic composition (C=C). Europeans also
show a quite high occurrence (24.4%) of a mutation
on both genes, Sub-Saharan Africans only 3.3%.
The same phenomenon can be observed in
Rs16952819 and Rs9893392, both located in the
non-coding region. Especially Rs9893392 seems to
be under a high pressure of genetic drift. Thus, there
are no European, Han Chinese, and Japanese people
who feature the original code (C=C), and only 17.4%
of African Americans. Instead, the majority exhibits
a mutation on both genes. 64% of Europeans, about
93% of Han Chinese people, and even all tested
Japanese people show this double mutation.
It is noticeable, that some populations are more
burdened with mutations than other ones. This fact
was described in a work by Lohmueller et al. [25].
Having analyzed the DNA of 20 European Americans
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Table 1 SNPs in OR3A1 with their location, concerned amino acids, and percental occurrence in different populations. Total
percentage (occurrence in all tested women; occurrence in all tested men)
Rs16952828
Genomic location: Chr. 17, 3142369 to 3142420 ()
Alternate residues: S, G
T=T C=T C=C
European 100% 0% 0%
Han Chinese 100% 0% 0%
Japanese 100% 0% 0%
Sub-Saharan African 93.8% (93.3%; 82.0%) 6.2% (2.7%; 18.0%) 0%
African American 91.3% (83.4%; 100%) 8.7% (16.6%; 0%) 0%
Rs7218125
Genomic location: Chr. 17, 3142327 to 3142378 ()
Alternate residues: K, 
T=T A=T A=A
European 100% 0% 0%
Han Chinese 95.6% (100%; 90.9%) 4.4% (0%; 9.1%) 0%
Japanese 95.5% (100%; 90.9%) 4.5% (0%; 9.1%) 0%
Sub-Saharan African 90% (94.6%; 86.8%) 10% (5.4%; 13.2%) 0%
African American 87% (91.7%; 81.8%) 13% (8.3%; 18.2%) 0%
Rs703903
Genomic location: Chr. 17, 3142227 to 3142278 ()
Alternate residues: Q, R
C=C C=T T=T
European 27.9% (17.4%; 38.6%) 47.7% (58.7%; 36.4%) 24.4% (23.9%; 25.0%)
Han Chinese 0% 0% 100%
Japanese 0% 0% 100%
Sub-Saharan African 47.8% (56.8%; 41.5%) 48.9% (37.8%; 56.6%) 3.3% (5.4%; 1.9%)
Rs16952819
Genomic location: Chr. 17, 3139769 to 3139820 () (non-coding region)
C=C C=T T=T
European 0% 50.0% (66.6%; 52.2%) 50.0% (33.4%; 47.8%)
African American 52.3% (8.4%; 18.3%) 13.0% (66.6%; 36.3%) 34.7% (25.0%; 45.4%)
Rs9893392
Genomic location: Chr. 17, 3140447 to 3140498 () (non-coding region)
C=C C=T T=T
European 0% 36.0% (29.8%; 41.1%) 64.0% (70.2%; 58.0%)
Han Chinese 0% 6.7% (8.7%; 4.5%) 93.3% (91.3%; 95.5%)
Japanese 0% 0% 100%
African American 17.4% (16.6%; 18.1%) 43.5% (50%; 36.4%) 39.1% (33.4%; 45.5%)
Rs7214042
Genomic location: Chr. 17, 3142676 to 3142727 () (non-coding region)
C=C A=C A=A
European 100% 0% 0%
Han Chinese 100% 0% 0%
Japanese 100% 0% 0%
Sub-Saharan African 100% 0% 0%
American African 100% 0% 0%
(continued)
and 15 African Americans, these researchers found
that Europeans contain a lower genetic diversity
compared to African Americans. These results are
in agreement with the hypothesis that after migrating
out of Africa, human groups experienced a popula-
tion ‘‘bottleneck’’ in which their genetic diversity
was reduced. Expanding quickly, the European pop-
ulation accumulated new mutations before the old
ones that cause negative implication could be
weeded out [26]. This might be an explanation for
the above mentioned fact that Africans are supposed
to have a larger functional olfactory receptor reper-
toire than other populations.
But the question remains, why just the strongest
genetic drift can be observed in non-coding regions
and whether mutations in this area are important for
odorant receptors.
Some groups showed that in general changes in
non-coding DNA can have a tremendous impact on
phenotype including drug response [27], disease sus-
ceptibility [28–30], and the evolution of differences
between species [31]. In terms of odorant receptors
in special, the dimension of influence by mutations
in non-coding regions is not proved yet, and much
more experiments and analysis will be required to
draw conclusions how SNPs and odorant perception
are related to each other.Fig. 1 Location of SNPs in receptor model of human OR3A1
Table 1 (continued)
Rs4790459
Genomic location: Chr. 17, 3139926 to 3139977 () (non-coding region)
G=G A=G A=A
European 100% 0% 0%
Han Chinese 86.7% (78.3%; 95.5%) 13.3% (21.7%; 4.5%) 0%
Japanese 97.8% (100%; 95.7%) 2.2% (0%; 4.3%) 0%
Sub-Saharan African 100% 0% 0%
Rs2676604
Genomic location: Chr. 17, 3142696 to 3142747 () (non-coding region)
C=C C=T T=T
European 100% 0% 0%
Han Chinese 100% 0% 0%
Japanese 100% 0% 0%
Sub-Saharan African 90% (89.2%; 90.6%) 10% (10.8%; 9.4%) 0%
Rs2317892
Genomic location: Chr. 17, 3140682 to 3140733 () (non-coding region)
G=G A=G A=A
European 85.1% (87.7%; 82.5%) 14.9% (12.3%; 17.5%) 0%
Han Chinese 26.8% (39.2%; 14.2%) 46.6% (39.1%; 54.5%) 26.6% (21.7%; 31.8%)
Japanese 26.2% (22.8%; 26.1%) 51.1% (54.5%; 47.8%) 24.4% (22.7%; 26.1%)
Sub-Saharan African 100% 0% 0%
African American 91.3% (83.4%; 100%) 8.7% (16.6%; 0%) 0%
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Comparison of two human genomes
Just seven years ago, the first sequence and analysis
of the human genome has been published simulta-
neously in two draft versions, one in Nature [32] and
the other one in Science [33]. Both of these versions
are composite sequences derived from haploid ge-
nomes of mostly anonymous donors [34].
But such studies cannot detect rare alleles related
to diseases or reflecting individual peculiarities. On-
ly sequencing the genome of individuals who are
willing to reveal relevant details about their personal
life will offer the opportunity to explore the complex
interactions between different alleles, their regulato-
ry elements and the individual’s environment, which
determines typical physical characteristics, and
therefore make it possible to correlate genomic var-
iations with a specific phenotype [35].
Now, two entire genome sequences of two individ-
uals, Craig Venter and James Watson, are accessible
for public and will help to encourage the develop-
ment of an area of personalized genomic medicine
with the intent to identify and prevent diseases and
to create personalized medical therapies.
In May 2007, the sequencing of the six billion
base pairs of James Watson’s DNA has been finished
and released to the public through the web site
www.jimwatsonsequence.cshl.edu. Only a few months
later, in September 2007, researchers of the Craig
Venter Institute in Rockville, USA, have published
the diploid genome sequence of Craig Venter, in
which his two sets of chromosomes (one inherited
from his mother and one from his father) are repre-
sented [35]. It is available in GenBank under the
code ABBA00000000, though not yet assembled.
This genome project shows that an individual hu-
man has about 4.1 million DNA variants (including
1.2 million variants that have never been seen be-
fore) and 3.2 million of these are SNPs. It conveys
that human to human variation is 5 to 7 times greater
compared to previous human genome analyses [35].
Over the next 3 years, an international team plans to
sequence the genomes of 1000 individuals. The so
called ‘‘1000 Genome Project’’ will serve as gold-stan-
dard reference for analysis of human variations [36].
For odorant receptor research it would be interest-
ing to have the opportunity to explore why individu-
al people have a different sense of smell. So, maybe
in future it will be possible to create the most pleas-
ant fragrance for an individual or a special popu-
lation after having analyzed their odorant receptor
genes and built the ligand that stimulates the desired
receptor(s) most efficiently.
To show that there exist vast variations from hu-
man to human, a choice of olfactory receptors genes
of Venter’s and Watson’s genome was compared with
each other. Additionally, they were compared to the
sequences from HORDE as reference. For this com-
parison, the six human odorant receptors with known
ligands plus four additional receptors including one
pseudogene (OR10B1P) were selected.
First of all, Venter’s and Watson’s nucleic acid
sequences were searched with the help of NCBI
Blast respectively Jim Watson Genome Browser,
using HORDE sequences as query. After having
aligned them with ClustalW, they were transformed
into protein sequences with Transeq in case that the
alignments showed some differences in the nucleo-
tide sequence. The protein sequences were aligned to
identify some silent mutations and to examine the
variations in detail.
When comparing all those odorant receptors, it is
conspicuous that JamesWatson’s sequences are always
completely concordant with the HORDE references.
Unlike that, Craig Venter’s olfactory genes show
many variations in comparison to the reference and
therefore also to Watson’s OR genes. All found dif-
ferences concerning Venter are summed up in Table 2.
As apparent, three of the examined receptors
(OR1D2, OR1G1, and OR7D4) are completely alike
both in Venter’s and Watson’s genome. Some others
show many differences, like OR51M1 with seven















OR1A1 3 1 2
OR1A2 4 2 2
OR3A1 1 1 0
OR1D2 0 0 0
OR1G1 0 0 0
OR7D4 0 0 0
OR52D1 5 1 4
OR52J3 4 2 1
OR51M1 7 6 1
OR10B1P 7 ? ?
OR10B1P¼ pseudogene
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variations in nucleotide sequence and still six differ-
ences in protein sequence, or OR1A2, that features
four mutations in nucleic acid sequence and two in
protein sequence. This receptor shall serve as exam-
ple to examine the variations in detail.
There are four mutations in Venter’s olfactory
gene. The first mutation, on position 15, is annotated
in SNP Database as Rs2241093. This synonymous
variation feature 35% of Caucasian people like Craig
Venter [37]; 65% possess the ancestral base thymine.
The next mutation, which is named Rs2241092 and
located at position 264, is also a synonymous one.
Only 7.5% of people of Venter’s ancestry hold this
genomic variant. Mutations in positions 766 and
879, Rs2241091 and Rs12150427, are both non-
synonymous and can be found in around 30% of
Caucasian people. These two variations determine
differences in the protein sequences.
Craig Venter possesses a cysteine residue in posi-
tion 256 instead of a glycine, and another cysteine
in position 293 in place of a tryptophan residue.
Regarding chemical properties, the change of those
amino acids causes substantial differences. In both
cases, a non-polar residue was replaced by a polar
one, which contains a sulfide and therefore has a
higher chemical reactivity. Moreover, varieties can be
suggested considering the size of residues. Tryptophan
is a large amino acid containing an aromatic indole
group while cysteine is somewhat smaller.
Probably even more important than the kind of
substitution is the location. If the mutation takes
place in a highly variable region it might not cause
any shifts in receptor function whereas changes con-
cerning binding pockets will influence the ligand
binding and therefore the receptor function and
sense of smell.
Position 293 is situated at the intracellular C-ter-
minus, which follows TM7. This region is not very
important for ligand binding but for binding of the
G-protein and other signalling molecules. However,
it can be assumed that this variation might not influ-
ence the function of OR1A2. In contrast, position
256 is located near a putative binding site in helix
6. Therefore, it is possible, that mutations in this po-
sition might influence the ligand binding indirectly.
To get an idea about the conservation of those
positions, an alignment of protein sequences of
OR1A2 and the closely related OR1A1 were made,
containing human sequences as well as chimpanzee
ones because of the evolutionary relation. Obviously,
all sequences feature a glycine in position 256 ex-
cept Craig Venter. Residues in position 293 vary:
human and chimpanzee OR1A1 show an arginine
residue, but OR1A2 sequences all have a tryptophan
with the exception of Craig Venter. This might con-
firm the hypothesis that position 256 is of higher
importance than position 293.
This example shows the possible differences in
odorant receptor function. Regarding the fact that
there are around 800 human odorant receptors, of
those many contain mutations from human to human,
it is virtually certain that two individuals like Venter
Fig. 2 Alignment of protein sequences of OR1A1 and OR1A2: HORDE sequence (hOR), chimpanzee sequence (P), and
Venter’s sequence (V)
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and Watson have a different sense of smell with un-
equal preferences and disfavors, which also cause dif-
ferent patterns in behavior. To entirely discover the
correlation between the complex sense of smell and
inter-individual variations it will be a long way but the
‘‘1000 Genome Project’’ will be one step forward.
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